The Editor's roundtable: cyclooxygenase-2 inhibitors and cardiovascular risk.
Bresalier
Robert S
RS
Department of Gastrointestinal, Medicine and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Friedewald
Vincent E
VE
Rakel
Robert E
RE
Roberts
William C
WC
Williams
Gary W
GW
D000544:Alzheimer Disease / Q000517:prevention & control; D001168:Arthritis / Q000188:drug therapy; D002318:Cardiovascular Diseases / Q000453:epidemiology / Q000209:etiology*; D000075202:Contraindications; D052246:Cyclooxygenase 2 Inhibitors / Q000627:therapeutic use; D014943:Global Health; D006801:Humans; D015994:Incidence; D012307:Risk Factors
D052246:Cyclooxygenase 2 Inhibitors